Clinical Trials

52 enrolled

Pancreatic Neoplasms

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

BreastGastrointestinalThoracic

260 enrolled

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05832892 2024-06-14

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

41 enrolled

Pancreatic Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

20 enrolled

Pancreatic Neoplasms, Rectal Neoplasms

NCT06308406 2024-04-11

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

54 enrolled

Ovarian Neoplasms

NCT04780217 2024-03-04

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

GastrointestinalGynecologic

42 enrolled

Carcinoma, Hepatocellular, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03643549 2024-02-29

BORTEM-17

63 enrolled

CNS

Glioblastoma, Recurrence

NCT04330820 2024-02-28

RELAX

Other hematologic neoplasm

55 enrolled

Leukemia, Myeloid, Acute

NCT06279767 2024-02-28

Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

27 enrolled

CNS

Glioblastoma, Neoplasms

NCT03576378 2024-02-26

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

41 enrolled

Lymphoid

Hodgkin Disease

NCT05575804 2024-02-26

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

75 enrolled

Breast

Advanced/ Metastatic Her-2 Positive Breast Cancer

NCT01754402 2024-02-20

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

56 enrolled 12 charts

Plasma cell

Multiple Myeloma

NCT04934514 2024-02-20

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

97 enrolled

Advanced Solid Tumor

NCT05991518 2024-02-20

IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

136 enrolled

HER2 Gene Mutation

NCT02730923 2024-02-13

VICTORIA

72 enrolled

Carcinoma, Endometrial Neoplasms

NCT06255262 2024-02-13

Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

30 enrolled

Biliary Tract Neoplasms

NCT04984668 2024-02-09

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

216 enrolled

Solid Tumor

NCT05842317 2024-02-09

Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC

Carcinoma, Hepatocellular

NCT06074029 2024-02-08

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

50 enrolled

Biliary Tract Neoplasms

NCT05358379 2024-02-07

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

330 enrolled

Lymphoid

Lymphoma

NCT04358393 2024-02-01

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

MyeloidOther hematologic neoplasm

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06237400 2024-02-01

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

110 enrolled

KRAS G12C Mutant Advanced Solid Tumors

NCT03789097 2024-01-30

Vaccination With Flt3L, Radiation, and Poly-ICLC

BreastHead & NeckLymphoid

56 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT05675605 2024-01-30

A Study of TY-1091 in Patients With Advanced Solid Tumors

248 enrolled

Neoplasms, Carcinoma, Medullary

NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Other solid neoplasmThoracic

186 enrolled

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

NCT06223308 2024-01-25

A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors

54 enrolled

Uterine Cervical Neoplasms

NCT05576961 2024-01-23

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Solid Tumor

NCT05464173 2024-01-22

CINDERELLA

44 enrolled

Breast

Breast Neoplasms

NCT04284228 2024-01-16

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

MyeloidOther hematologic neoplasm

22 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05906524 2024-01-10

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

85 enrolled

Advanced HCC

NCT05522738 2024-01-08

Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

46 enrolled

Colorectal Neoplasms

NCT04720768 2024-01-05

CELEBRATE

78 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT03807102 2023-12-29

TVATLC01

30 enrolled

Thoracic

Lung Neoplasms

NCT04714827 2023-12-29

Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma

24 enrolled

Plasma cell

Multiple Myeloma

NCT06172634 2023-12-15

DICI_PC

10 enrolled

Pancreatic Neoplasms

NCT06168552 2023-12-13

CISPD-6

20 enrolled

Resectable Pancreatic Adenocarcinoma

NCT03638375 2023-12-12

ACTME

34 enrolled

Dermatologic

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT04407741 2023-12-12

Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas

100 enrolled

Lymphoid

Lymphoma

NCT05705505 2023-12-12

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Endometrioid Endometrial Cancer

NCT05432934 2023-12-07

TAP-DEX

Diverticular Diseases, Agnosia, Crohn Disease, Pain, Postoperative, Colorectal Neoplasms

NCT05289076 2023-12-01

CRLM-Z

40 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT02935205 2023-11-29

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

38 enrolled

Genitourinary

Prostatic Neoplasms

NCT03614858 2023-11-29

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

LymphoidOther hematologic neoplasm

20 enrolled

Leukemia, B-Cell

NCT03896854 2023-11-29

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Other hematologic neoplasm

15 enrolled

Leukemia, Myeloid, Acute

NCT05580445 2023-11-22

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

114 enrolled

Advanced Pancreatic Cancer

NCT02557321 2023-11-21

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

50 enrolled

Dermatologic

Melanoma

NCT04253145 2023-11-18

Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

184 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06136910 2023-11-18

Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer

30 enrolled

Thoracic

Untreated Advanced Non-small Cell Lung Cancer

NCT06126237 2023-11-13

A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma